期刊文献+

囊性肾癌临床特点及诊治分析 被引量:4

Experience on diagnosis and treatment of cystic renal cell carcinoma
下载PDF
导出
摘要 目的:分析囊性肾癌的临床特点,探讨囊性肾癌的诊断及治疗方法。方法回顾性分析12例囊性肾癌患者的临床表现、影像学特征、手术方法、病理特征及随访结果,并结合相关文献就其临床特点进行讨论。结果12例患者术后病理结果透明细胞癌10例,嫌色细胞癌2例。肿瘤直径1.5~8.5cm,平均4.4cm。TNM分期:T1N0M010例,T2N0M02例,其中多房囊性肾癌7例,单房囊性肾癌5例。随访13~78个月,平均39个月,均无复发和转移。结论囊性肾癌早期诊断较为困难,应结合影像学检查、术中冰冻切片及术后病理结果确诊。囊性肾癌恶性度低,预后较好。囊性肾癌同肾癌一样采用肾癌根治术或保留肾单位的手术,保留肾单位的手术为治疗的最佳选择。 Objective To analyze clinical features of cystic renal cell carciuoma ( CRCC) and to investigate the diagnosis and treatment of CRCC .Methods The clinical data of 12 cases with CRCC was analyzed retrospectively .The clinical presen-tation,radiologic features ,surgical procedures ,pathologic features as well as follow -up outcomes of the CRCC were stud-ied.Clinical characteristics were discussed combining references .Results The diagnoses of CRCC were confirmed by post-operative pathology .Histological examination showed that 10 cases of clear cell carcinoma and 2 cases of chromophobe car-cinoma.The size of the tumors ranged from 1.5 cm to 8.5 cm with an average of 4.4 cm.Ten cases were classified as T1N0 M0 and two cases as T2N0M0 for TNM staging.Histopathologic examination demonstrated multilocular cystic renal cell car-cinoma in 7 cases and unilocular cystic renal cell carcinoma in 5 cases.All of the patients remained tumor -free with no ev-idence of neoplastic recurrence or metastasis during a 13 to 78 months (39 months in average ) follow-up.Conclusion Early diagnosis of CRCC is difficult and should be combined with preoperative imaging , intraoperative frozen section and postoperative pathologic examination .Patients with CRCC show relatively good prognosis .CRCC should be treated the same as renal cell carciuoma by radical nephrectomy or partial nephrectomy .Nephron sparing surgery is the optimum choice .
出处 《大连医科大学学报》 CAS 2014年第1期65-67,共3页 Journal of Dalian Medical University
关键词 囊性肾癌 诊断 肾癌根治术 保留肾单位手术 cystic renal cell carcinoma diagnosis radical nephrectomy nephron sparing surgery
  • 相关文献

参考文献7

二级参考文献36

  • 1陆明园,温淑英,郑鹏宇,孙晓光,王毅纯.囊性肾癌的CT诊断[J].中国医学影像技术,2008,24(S1):143-144. 被引量:15
  • 2孙小林,钱立新,叶新华,邵鹏飞.Sonovue超声造影对肾脏占位诊断的价值[J].江苏医药,2007,33(7):731-732. 被引量:2
  • 3Nassir A, Jollimore J, Gupta R, et al. Multilocular cystic renal cell eareinoma:a series of 12 eases and review of the literature[J]. Urology, 2002, 60(3):421-427.
  • 4Suzigan S,Montironi R,Drut R, et al. Multilocular cystic renal cell carcinoma : a report of 45 eases of a kidney tumor of low malignant potential[J].Am J Clin Pathol, 2006,125(2):217- 222.
  • 5Lopez Beltran A, Scarpelli M, Montironi R, et al. 2004 WHO classification of renal tumors of the adults[J]. Eur Urol,2006, 49(5) : 798-805.
  • 6王国民.肾囊性疾病[M]//吴阶平.吴阶平泌尿外科学.济南:山东科学技术出版社,2005:1717.
  • 7Halat SK, Maclennan GT. Multilocular cystic renal cell carcinoma[J].J Urol, 2007,177(1) :343.
  • 8Warren KS, Mcfarlane J. The bosniak classification of renal cystic masses[J]. BJU Int, 2005. 95(7): 939 942.
  • 9Aubert S, Zini L, Delomez J, et al. Cystic renal cell carcinoma in adults: is preoperative recognition of multilocular cystic renal cell carcinoma possible[J]. J Urol, 2005, 174(6):2115-2119.
  • 10刘硕 孙光 刘晓强 等.多房性囊性肾癌8例报告.中华泌尿外科杂志,2008,29(4):232-232.

共引文献29

同被引文献39

  • 1麻继红,赵玉珍,王小玲,纪晓惠,叶卫华.肾癌三维彩色血管定量与病理组织学分级及微血管密度的相关研究[J].中国超声医学杂志,2005,21(9):687-690. 被引量:7
  • 2薛莉,王爱露,孙大雪.囊性肾癌的超声诊断与误诊分析[J].中华超声影像学杂志,2005,14(12):954-955. 被引量:5
  • 3李吉昌,刘绍玲,牛司华,吴宗桧,石珊.囊性肾癌超声分型及其诊断价值的探讨[J].中华超声影像学杂志,2006,15(2):159-160. 被引量:21
  • 4周建军,周康荣,曾蒙苏,王建华,丁建国,纪元.多房囊性肾细胞癌动态增强CT表现[J].中国临床医学影像杂志,2007,18(11):796-799. 被引量:46
  • 5Conti A, Santoni M, Amantini C, et al. Progress of Molecular Tar geted Therapies for Advanced Renal Cell Carcinoma[J]. Biomed Res Int, 2013,2013:419176.
  • 6Scartozzi M, 13ianconi M, Faloppi L, et al. VEGF and VEGFR polymor- phisms affect clinical outcome in advanced renal cell carcinoma patients re- ceiving first-line SunitinihrJ:. Br J Cancer,2013,108(5) :1126- 1132.
  • 7Arjan W, Laurie A, Annemarie M, et al. Rapid angiogenesis onset after discontinuation of sunitinib treatment of renal cell carcinoma patients[J]. Clin Cancer Res,2012,18(14) :3961-3971.
  • 8Chow L Q,Eckhardt S G, Sunitinib:From rational design to clinical efficacy[J].J Clin Oncol,2007,25(7) :884-896.
  • 9Schlessinger J. Cell signaling hy receptor tyrosine kinases:J :. Cell, 2000,103(2) :211-225.
  • 10Demetri G D:van Oosterom A T,Garrett C R,et al. Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal turn our after failure of imatinib: a randomised controlled trial[J]. Lancet, 2006,368(9544) :1329- 1338.

引证文献4

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部